Category: Synnovis

SYNLAB UK&I appoints new Synnovis CEO

SYNLAB UK & Ireland is delighted to announce the appointment of Tom Evans as Chief Executive Officer of Synnovis, its NHS partnership in South East London. The appointment reflects the strategic importance of Synnovis to both SYNLAB UK & Ireland and SYNLAB Group, and signals the next stage in the delivery of its agreed operating […]

BREEAM Synnovis Hub Excellent Certification

We are delighted to announce that the Synnovis hub has officially achieved BREEAM Excellent Certification! Building Research Establishment Environmental Assessment Method (BREEAM) is one the longest running assessors for sustainability. By achieving a BREEAM Excellent certification, Synnovis is showing it’s committed to our Environmental, Social, and Governance (ESG) goals.  An excellent rating indicates that the building has […]

Blackfriars hub: 2 years old today!

Synnovis released this infographic to celebrate the second anniversary of its Blackfriars hub and to capture the scale and scope of what has been achieved. The first live pathology samples were processed at the hub on 2 April 2024. Since then, the volume of tests processed has doubled year on year, with 22.5million tests processed in [...]

Cyber Essentials Plus (CE+) Accreditation

Synnovis has achieved Cyber Essentials Plus (CE+) Accreditation following an independent Audit. CE+ is the highest level of certification for cyber security currently recommended by the UK government. It involves an intense technical audit, including device checks and internal and external scans, to verify that core controls implemented by an organisation are working effectively. This […]

Synnovis completes forensic review following 2024 cyberattack — notifications under way

Synnovis, a pathology partnership between Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospitals NHS Trust and SYNLAB, has completed the forensic investigation of the data stolen from our systems following the ransomware cyberattack we experienced last year. This calculated attack on critical UK healthcare infrastructure impacted almost all Synnovis IT systems and resulted […]

Spinal Muscular Atrophy (SMA) – Rapid test now available

We are pleased to offer a new digital PCR test for the rapid diagnosis of Spinal Muscular Atrophy (SMA), a severe, progressive neuromuscular disorder caused by genetic mutations or deletions of the SMN1 gene. SMA patients present as “floppy infants”, with early onset of muscle weakness and failure to achieve motor milestones. In the most [...]

Phlebotomy Service Goes Digital 

Introducing Swiftqueue Starting on the 29th August, patients will need to book their blood tests online using Swiftqueue. They can do this using their mobile device, computer or by using the kiosks located in phlebotomy clinic waiting areas. Patients under 16 can be added to a family member or guardians Swiftqueue account. Once added, an appointment […]

SYNLAB Peer-2-Peer Lectures by the Future Leaders in Innovation

Established in 2013, the Future Leaders in Innovation are a group of like-minded employees who strive to promote and encourage positive change at Synnovis. During a two-year programme, they are encouraged to develop, lead and manage a number of initiatives including Synnovis Quality Day, Connect, Synnovis Career Development Programme and the Future Leader’s Podcast Series. […]